- Home
- Publications
- Publication Search
- Publication Details
Title
Prophylactic HPV vaccination: past, present, and future
Authors
Keywords
-
Journal
EPIDEMIOLOGY AND INFECTION
Volume 144, Issue 03, Pages 449-468
Publisher
Cambridge University Press (CUP)
Online
2015-10-02
DOI
10.1017/s0950268815002198
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States
- (2015) Susan Hariri et al. CANCER
- Dose-Related Differences in Effectiveness of Human Papillomavirus Vaccination Against Genital Warts: A Nationwide Study of 550 000 Young Girls
- (2015) Maria Blomberg et al. CLINICAL INFECTIOUS DISEASES
- Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis
- (2015) Mélanie Drolet et al. LANCET INFECTIOUS DISEASES
- Efficacy of fewer than three doses of an HPV-16/18 AS04-adjuvanted vaccine: combined analysis of data from the Costa Rica Vaccine and PATRICIA trials
- (2015) Aimée R Kreimer et al. LANCET ONCOLOGY
- A 9-Valent HPV Vaccine against Infection and Intraepithelial Neoplasia in Women
- (2015) Elmar A. Joura et al. NEW ENGLAND JOURNAL OF MEDICINE
- An Open-Label, Randomized Study of a 9-Valent Human Papillomavirus Vaccine Given Concomitantly with Diphtheria, Tetanus, Pertussis and Poliomyelitis Vaccines to Healthy Adolescents 11–15 Years of Age
- (2015) Pope Kosalaraksa et al. PEDIATRIC INFECTIOUS DISEASE JOURNAL
- Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States – 2008–2012
- (2015) Susan Hariri et al. VACCINE
- The use of hybrid virus-like particles to enhance the immunogenicity of a broadly protective HPV vaccine
- (2014) Mitchell Tyler et al. BIOTECHNOLOGY AND BIOENGINEERING
- Is expanding HPV vaccination programs to include school-aged boys likely to be value-for-money: a cost-utility analysis in a country with an existing school-girl program
- (2014) Amber L Pearson et al. BMC INFECTIOUS DISEASES
- HPV genotypes and cervical intraepithelial neoplasia in a multiethnic cohort in the southeastern USA
- (2014) Adriana C. Vidal et al. CANCER CAUSES & CONTROL
- Human Papillomavirus Genotype-Specific Prevalence across the Continuum of Cervical Neoplasia and Cancer
- (2014) N. E. Joste et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Association of Varying Number of Doses of Quadrivalent Human Papillomavirus Vaccine With Incidence of Condyloma
- (2014) Eva Herweijer et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Too Late to Vaccinate? The Incremental Benefits and Cost-effectiveness of a Delayed Catch-up Program Using the 4-Valent Human Papillomavirus Vaccine in Norway
- (2014) Emily A. Burger et al. JOURNAL OF INFECTIOUS DISEASES
- Risk of Newly Detected Infections and Cervical Abnormalities in Women Seropositive for Naturally Acquired Human Papillomavirus Type 16/18 Antibodies: Analysis of the Control Arm of PATRICIA
- (2014) Xavier Castellsagué et al. JOURNAL OF INFECTIOUS DISEASES
- Seroprevalence of 8 Oncogenic Human Papillomavirus Genotypes and Acquired Immunity Against Reinfection
- (2014) L. Wilson et al. JOURNAL OF INFECTIOUS DISEASES
- Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia--Nationwide Follow-up of Young Danish Women
- (2014) B. Baldur-Felskov et al. JNCI-Journal of the National Cancer Institute
- Assessment of herd immunity and cross-protection after a human papillomavirus vaccination programme in Australia: a repeat cross-sectional study
- (2014) Sepehr N Tabrizi et al. LANCET INFECTIOUS DISEASES
- Immunogenicity of a prophylactic quadrivalent human papillomavirus L1 virus-like particle vaccine in male and female adolescent transplant recipients
- (2014) V. Gomez-Lobo et al. PEDIATRIC TRANSPLANTATION
- Long-term Study of a Quadrivalent Human Papillomavirus Vaccine
- (2014) D. Ferris et al. PEDIATRICS
- Safety and immunogenicity of a quadrivalent human papillomavirus vaccine in HIV-infected and HIV-negative adolescents and young adults
- (2014) Vania Giacomet et al. VACCINE
- Adverse events following immunization in Ontario's female school-based HPV program
- (2014) Tara Harris et al. VACCINE
- Systematic review of human papillomavirus vaccine coadministration
- (2014) Alinea S. Noronha et al. VACCINE
- Immunization with a consensus epitope from human papillomavirus L2 induces antibodies that are broadly neutralizing
- (2014) Mitchell Tyler et al. VACCINE
- Neutralizing and cross-neutralizing antibody titres induced by bivalent and quadrivalent human papillomavirus vaccines in the target population of organized vaccination programmes
- (2014) Luisa Barzon et al. VACCINE
- Effectiveness of quadrivalent human papillomavirus vaccine for the prevention of cervical abnormalities: case-control study nested within a population based screening programme in Australia
- (2014) E. Crowe et al. BMJ-British Medical Journal
- Comparison of the immunogenicity of Cervarix®and Gardasil®human papillomavirus vaccines for oncogenic non-vaccine serotypes HPV-31, HPV-33, and HPV-45 in HIV-infected adults
- (2014) Lars Toft et al. Human Vaccines & Immunotherapeutics
- Sustained efficacy, immunogenicity, and safety of the HPV-16/18 AS04-adjuvanted vaccine
- (2014) Paulo S Naud et al. Human Vaccines & Immunotherapeutics
- Cost-effectiveness of female human papillomavirus vaccination in 179 countries: a PRIME modelling study
- (2014) Mark Jit et al. Lancet Global Health
- Clinical Progression of High-Grade Cervical Intraepithelial Neoplasia: Estimating the Time to Preclinical Cervical Cancer From Doubly Censored National Registry Data
- (2013) Margaretha A. Vink et al. AMERICAN JOURNAL OF EPIDEMIOLOGY
- The Occasional Role of Low-risk Human Papillomaviruses 6, 11, 42, 44, and 70 in Anogenital Carcinoma Defined by Laser Capture Microdissection/PCR Methodology
- (2013) Núria Guimerà et al. AMERICAN JOURNAL OF SURGICAL PATHOLOGY
- Immunogenicity of Quadrivalent Human Papillomavirus Vaccine in Organ Transplant Recipients
- (2013) D. Kumar et al. AMERICAN JOURNAL OF TRANSPLANTATION
- Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study
- (2013) Dorota M Gertig et al. BMC Medicine
- Age-Specific Occurrence of HPV16- and HPV18-Related Cervical Cancer
- (2013) S. de Sanjose et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Durable Antibody Responses Following One Dose of the Bivalent Human Papillomavirus L1 Virus-Like Particle Vaccine in the Costa Rica Vaccine Trial
- (2013) M. Safaeian et al. Cancer Prevention Research
- Lower cost strategies for triage of human papillomavirus DNA-positive women
- (2013) You-Lin Qiao et al. INTERNATIONAL JOURNAL OF CANCER
- Immunogenicity of 2 Doses of HPV Vaccine in Younger Adolescents vs 3 Doses in Young Women
- (2013) Simon R. M. Dobson et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Reduction in Human Papillomavirus (HPV) Prevalence Among Young Women Following HPV Vaccine Introduction in the United States, National Health and Nutrition Examination Surveys, 2003–2010
- (2013) Lauri E. Markowitz et al. JOURNAL OF INFECTIOUS DISEASES
- No Evidence for Synergy Between Human Papillomavirus Genotypes for the Risk of High-Grade Squamous Intraepithelial Lesions in a Large Population-Based Study
- (2013) Nicolas Wentzensen et al. JOURNAL OF INFECTIOUS DISEASES
- Efficacy of the HPV-16/18 AS04-Adjuvanted Vaccine Against Low-Risk HPV Types (PATRICIA Randomized Trial): An Unexpected Observation
- (2013) A. Szarewski et al. JOURNAL OF INFECTIOUS DISEASES
- Benchmarking CIN 3+ Risk as the Basis for Incorporating HPV and Pap Cotesting into Cervical Screening and Management Guidelines
- (2013) Hormuzd A. Katki et al. Journal of Lower Genital Tract Disease
- Screening for Cervical Cancer Precursors With p16/Ki-67 Dual-Stained Cytology: Results of the PALMS Study
- (2013) Hans Ikenberg et al. JNCI-Journal of the National Cancer Institute
- Annual Report to the Nation on the Status of Cancer, 1975–2009, Featuring the Burden and Trends in Human Papillomavirus (HPV)–Associated Cancers and HPV Vaccination Coverage Levels
- (2013) Ahmedin Jemal et al. JNCI-Journal of the National Cancer Institute
- Sexuality and Sexual Health: Constructs and Expressions in the Extended Middle East and North Africa
- (2013) Faysal El-Kak VACCINE
- Burden of Human Papillomavirus Infections and Related Diseases in the Extended Middle East and North Africa Region
- (2013) Salvatore Vaccarella et al. VACCINE
- Autoimmune, neurological, and venous thromboembolic adverse events after immunisation of adolescent girls with quadrivalent human papillomavirus vaccine in Denmark and Sweden: cohort study
- (2013) L. Arnheim-Dahlstrom et al. BMJ-British Medical Journal
- Cross-protective vaccine efficacy of the bivalent HPV vaccine against HPV31 is associated with humoral immune responses
- (2013) Mahboobeh Safaeian et al. Human Vaccines & Immunotherapeutics
- Human papillomavirus vaccination in low-resource countries: lack of evidence to support vaccinating sexually active women
- (2012) V Tsu et al. BRITISH JOURNAL OF CANCER
- Achieving high coverage in Rwanda’s national human papillomavirus vaccination programme
- (2012) Agnes Binagwaho et al. BULLETIN OF THE WORLD HEALTH ORGANIZATION
- Contributions of Recent and Past Sexual Partnerships on Incident Human Papillomavirus Detection: Acquisition and Reactivation in Older Women
- (2012) A. F. Rositch et al. CANCER RESEARCH
- Intranasal Vaccination with AAV5 and 9 Vectors Against Human Papillomavirus Type 16 in Rhesus Macaques
- (2012) Karen Nieto et al. HUMAN GENE THERAPY
- Human papillomavirus types in 115,789 HPV-positive women: A meta-analysis from cervical infection to cancer
- (2012) Peng Guan et al. INTERNATIONAL JOURNAL OF CANCER
- A population-based study of human papillomavirus genotype prevalence in the United States: Baseline measures prior to mass human papillomavirus vaccination
- (2012) Cosette M. Wheeler et al. INTERNATIONAL JOURNAL OF CANCER
- Fall in Human Papillomavirus Prevalence Following a National Vaccination Program
- (2012) S. N. Tabrizi et al. JOURNAL OF INFECTIOUS DISEASES
- The Lower Anogenital Squamous Terminology Standardization Project for HPV-Associated Lesions
- (2012) Teresa M. Darragh et al. Journal of Lower Genital Tract Disease
- Methylation of Human Papillomavirus Type 16 Genome and Risk of Cervical Precancer in a Costa Rican Population
- (2012) Lisa Mirabello et al. JNCI-Journal of the National Cancer Institute
- Methylation of HPV18, HPV31, and HPV45 Genomes and Cervical Intraepithelial Neoplasia Grade 3
- (2012) Nicolas Wentzensen et al. JNCI-Journal of the National Cancer Institute
- Cross-protective efficacy of two human papillomavirus vaccines: a systematic review and meta-analysis
- (2012) Talía Malagón et al. LANCET INFECTIOUS DISEASES
- Global Burden of Human Papillomavirus and Related Diseases
- (2012) David Forman et al. VACCINE
- Kinetic and HPV infection effects on cross-type neutralizing antibody and avidity responses induced by Cervarix®
- (2012) Troy J. Kemp et al. VACCINE
- Evaluation of HPV-16 and HPV-18 Genotyping for the Triage of Women With High-Risk HPV+ Cytology-Negative Results
- (2011) Thomas C. Wright et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Comparative immunogenicity and safety of human papillomavirus (HPV)-16/18 vaccine and HPV-6/11/16/18 vaccine
- (2011) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Eurogin 2010 roadmap on cervical cancer prevention
- (2011) Silvia Franceschi et al. INTERNATIONAL JOURNAL OF CANCER
- Time since first sexual intercourse and the risk of cervical cancer
- (2011) Martyn Plummer et al. INTERNATIONAL JOURNAL OF CANCER
- Immunogenicity and Reactogenicity of Alternative Schedules of HPV Vaccine in Vietnam
- (2011) Kathleen M. Neuzil JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- A Competitive Serological Assay Shows Naturally Acquired Immunity to Human Papillomavirus Infections in the Guanacaste Natural History Study
- (2011) Nicolas Wentzensen et al. JOURNAL OF INFECTIOUS DISEASES
- Incremental Impact of Adding Boys to Current Human Papillomavirus Vaccination Programs: Role of Herd Immunity
- (2011) Marc Brisson et al. JOURNAL OF INFECTIOUS DISEASES
- Proof-of-Principle Evaluation of the Efficacy of Fewer Than Three Doses of a Bivalent HPV16/18 Vaccine
- (2011) Aimée R. Kreimer et al. JNCI-Journal of the National Cancer Institute
- Efficacy of a bivalent HPV 16/18 vaccine against anal HPV 16/18 infection among young women: a nested analysis within the Costa Rica Vaccine Trial
- (2011) Aimée R Kreimer et al. LANCET ONCOLOGY
- Overall efficacy of HPV-16/18 AS04-adjuvanted vaccine against grade 3 or greater cervical intraepithelial neoplasia: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Matti Lehtinen et al. LANCET ONCOLOGY
- Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial
- (2011) Cosette M Wheeler et al. LANCET ONCOLOGY
- Efficacy of Quadrivalent HPV Vaccine against HPV Infection and Disease in Males
- (2011) Anna R. Giuliano et al. NEW ENGLAND JOURNAL OF MEDICINE
- HPV Vaccine against Anal HPV Infection and Anal Intraepithelial Neoplasia
- (2011) Joel M. Palefsky et al. NEW ENGLAND JOURNAL OF MEDICINE
- The near disappearance of genital warts in young women 4 years after commencing a national human papillomavirus (HPV) vaccination programme
- (2011) T. R. H. Read et al. SEXUALLY TRANSMITTED INFECTIONS
- The cost-effectiveness of male HPV vaccination in the United States
- (2011) Harrell W. Chesson et al. VACCINE
- Monitoring the safety of quadrivalent human papillomavirus vaccine: Findings from the Vaccine Safety Datalink
- (2011) Julianne Gee et al. VACCINE
- Prevention of Persistent Human Papillomavirus Infection by an HPV16/18 Vaccine: A Community-Based Randomized Clinical Trial in Guanacaste, Costa Rica
- (2011) R. Herrero et al. Cancer Discovery
- Comparison of the immunogenicity and safety ofCervarix™ andGardasil®human papillomavirus (HPV) cervical cancer vaccines in healthy women aged 18–45 years
- (2010) Mark H. Einstein et al. Human vaccines & immunotherapeutics
- Safety and Immunogenicity of the Quadrivalent Human Papillomavirus Vaccine in HIV‐1–Infected Men
- (2010) Timothy Wilkin et al. JOURNAL OF INFECTIOUS DISEASES
- Preventing Cervical Cancer Globally by Acting Locally: If Not Now, When?
- (2010) Julia C. Gage et al. JNCI-Journal of the National Cancer Institute
- Long-term Absolute Risk of Cervical Intraepithelial Neoplasia Grade 3 or Worse Following Human Papillomavirus Infection: Role of Persistence
- (2010) S. K. Kjaer et al. JNCI-Journal of the National Cancer Institute
- Impact of Human Papillomavirus (HPV)-6/11/16/18 Vaccine on All HPV-Associated Genital Diseases in Young Women
- (2010) Nubia Muñoz et al. JNCI-Journal of the National Cancer Institute
- Quadrivalent human papillomavirus vaccination and trends in genital warts in Australia: analysis of national sentinel surveillance data
- (2010) Basil Donovan et al. LANCET INFECTIOUS DISEASES
- Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study
- (2010) Silvia de Sanjose et al. LANCET ONCOLOGY
- Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments
- (2010) Hans-Ulrich Bernard et al. VIROLOGY
- A Pooled Analysis of Continued Prophylactic Efficacy of Quadrivalent Human Papillomavirus (Types 6/11/16/18) Vaccine against High-grade Cervical and External Genital Lesions
- (2009) S. K. Kjaer et al. Cancer Prevention Research
- Concatenated Multitype L2 Fusion Proteins as Candidate Prophylactic Pan-Human Papillomavirus Vaccines
- (2009) Subhashini Jagu et al. JNCI-Journal of the National Cancer Institute
- Chimeric L1-L2 Virus-Like Particles as Potential Broad-Spectrum Human Papillomavirus Vaccines
- (2009) C. Schellenbacher et al. JOURNAL OF VIROLOGY
- Longer term efficacy of a prophylactic monovalent human papillomavirus type 16 vaccine
- (2009) Ali Rowhani-Rahbar et al. VACCINE
- Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline
- (2009) Mark Schiffman et al. Infectious Agents and Cancer
- International Correlation between Human Papillomavirus Prevalence and Cervical Cancer Incidence
- (2008) D. Maucort-Boulch et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Immunogenicity and Safety of Human Papillomavirus (HPV)-16/18 AS04-Adjuvanted Vaccine in Healthy Boys Aged 10–18 Years
- (2008) Tiina Petäjä et al. JOURNAL OF ADOLESCENT HEALTH
- Heterogeneity in CIN3 diagnosis
- (2008) Mark Schiffman et al. LANCET ONCOLOGY
- Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study
- (2008) Margaret RE McCredie et al. LANCET ONCOLOGY
- Health and Economic Implications of HPV Vaccination in the United States
- (2008) Jane J. Kim et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search